Back to Search
Start Over
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
- Source :
-
Blood [Blood] 2001 Sep 01; Vol. 98 (5), pp. 1626; author reply 1628. - Publication Year :
- 2001
- Subjects :
- Antiviral Agents administration & dosage
Antiviral Agents pharmacology
Cidofovir
Cytomegalovirus drug effects
Cytomegalovirus isolation & purification
Cytomegalovirus physiology
Cytomegalovirus Infections etiology
Cytomegalovirus Infections transmission
Cytosine administration & dosage
Cytosine analogs & derivatives
Cytosine pharmacology
Drug Resistance, Microbial
Drug Therapy, Combination
Foscarnet therapeutic use
Ganciclovir administration & dosage
Ganciclovir therapeutic use
Hematologic Neoplasms therapy
Humans
Myelodysplastic Syndromes therapy
Organophosphorus Compounds administration & dosage
Organophosphorus Compounds pharmacology
Prospective Studies
Treatment Failure
Viremia drug therapy
Viremia etiology
Virus Activation
Antiviral Agents therapeutic use
Cytomegalovirus Infections drug therapy
Cytosine therapeutic use
Hematopoietic Stem Cell Transplantation adverse effects
Organophosphonates
Organophosphorus Compounds therapeutic use
Transplantation, Homologous adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 0006-4971
- Volume :
- 98
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Report
- Accession number :
- 11547768
- Full Text :
- https://doi.org/10.1182/blood.v98.5.1626